KRT19 Antibody, Monoclonal
| Product name: | KRT19 Antibody, Monoclonal |
| Source: | Mouse |
| Purity: | >95% |
| Buffer Formulation: | 10 mM PBS, pH 7.4, 0.2% BSA, 0.09% sodium azide. |
| Applications: | IFIHCWB |
| Storage: | Store KRT19 antibody at 4 ˚C or -20 ˚C. As with all antibodies avoid freeze/thaw cycles. |
| UOM: | 100ug |
KRT19 Antibody, Monoclonal
Catalog Number:IC283112
Product Profile
| Product Name | KRT19 Antibody, Monoclonal |
|---|---|
| Antibody Type | Primary Antibodies |
| Productdescription |
|
| Immunogen |
KRT19 monoclonal antibody was raised against amino acids from the C-Terminus of KRT19 (Human). |
Key Feature
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2a,l |
| Host Species | Mouse |
| TestedApplications | |
|
KRT19 antibody can be used in ELISA, Western Blot starting at 1:500 - 1:2000, and immunohistochemistry starting at 10 μg/mL.:
|
|
| Species Reactivity | |
| Concentration | 1mg/ml |
| Purification | Protein G |
Target Information
| Gene Symbol | KRT19 |
|---|---|
| AlternativeNames |
KRT19
More
CK19 Cytokeratin 19 Cytokeratin-19 Keratin 19 Keratin-19 CK-19 K19 K1CS Keratin type I 40-kd |
| Tissue Specificity | Recognizes the rod domain of keratin 19 (40kD). Reacts with the MCF-7 cells, which are known to contain keratin 19. It shows no reaction with the cells lacking keratin 19 such as A431 and HeLa. |
Database Links
| Entrez Gene | 3880 |
|---|---|
| Protein Accession | P08727 |
Application
-
Application
Immunohistochemistry staining of KRT19 in uterus tissue using KRT19 monoclonal Antibody.
| ApplicationNotes |
KRT19 antibody can be used in ELISA, Western Blot starting at 1:500 - 1:2000, and immunohistochemistry starting at 10 μg/mL.:
|
|---|
Additional Information
| Form | Liquid |
|---|---|
| Storage Instructions | Store KRT19 antibody at 4 ˚C or -20 ˚C. As with all antibodies avoid freeze/thaw cycles. |
| Storage Buffer | 10 mM PBS, pH 7.4, 0.2% BSA, 0.09% sodium azide. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.












